{
    "key": "2013-0205",
    "name": "Dose 1 to dose 3 interval 16 weeks-5 days. 4th dose needed",
    "cdcTestId": "2013-0205",
    "changedInVersion": "4.2",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-18T08:03:22.977",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-04-28T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-06-04T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "All Valid: Forecast Test",
    "forecast": {
        "earliestDate": "2020-08-18T00:00:00",
        "forecastNum": "4",
        "pastDueDate": "2021-09-23T00:00:00",
        "recommendedDate": "2020-08-18T00:00:00"
    },
    "forecastTestType": "Recommended based on interval ",
    "generalDescription": "This test case describes when dose #3 of the Hep B vaccine is administered at an interval less than 16 weeks - 4 days from dose #1 that the dose is considered to be valid, but a 4th dose is needed to complete the series.",
    "patient": {
        "dob": "2020-01-27T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-04-28T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-06-04T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ]
    },
    "reasonForChange": "V4.2: Updated Forecast Test Type to \"Recommended based on interval\".\nV4.1: Changed forecast to reflect new 4 dose guidance from CEB.\nV3.1: Changed dose 3 from valid to not valid due to Hep B 4 dose series",
    "testcaseName": "Dose 1 to dose 3 interval 16 weeks-5 days. 4th dose needed",
    "vaccineGroup": "HepB"
}